Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Ichimura

Showing results (251-260 of 298) with videos related to

Pageof 30
Sort By:
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
Acta Neuropathologica Communications|September 25, 2023
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group studyKohei Fukuoka, Jun Kurihara, Tomoko Shofuda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2023
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 CasesToru Odate, Kaishi Satomi, Takashi Kubo, et al.
Scientific Reports|August 8, 2018
Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomasHideyuki Arita, Manabu Kinoshita, Atsushi Kawaguchi, et al.
Neuro-Oncology|June 20, 2022
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomasAtsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, et al.
Acta Neuropathologica|August 31, 2017
Distinct molecular profile of diffuse cerebellar gliomasMasashi Nomura, Akitake Mukasa, Genta Nagae, et al.
Acta Neuropathologica|June 20, 2021
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaKenji Fujimoto, Hideyuki Arita, Kaishi Satomi, et al.
DEN Open|February 6, 2023
Local recurrence of submucosal invasive colorectal cancer after endoscopic submucosal dissection revealed by copy number variationYu Okazawa, Kiichi Sugimoto, Yuki Ii, et al.
Cancers|November 26, 2022
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker StudyMotoo Nagane, Koichi Ichimura, Ritsuko Onuki, et al.
Scientific Reports|September 21, 2023
Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumorsHirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Pageof 30

Showing results (251-260 of 298) with videos related to

Sort By:
Pageof 30
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
Acta Neuropathologica Communications|September 25, 2023
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group studyKohei Fukuoka, Jun Kurihara, Tomoko Shofuda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2023
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 CasesToru Odate, Kaishi Satomi, Takashi Kubo, et al.
Scientific Reports|August 8, 2018
Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomasHideyuki Arita, Manabu Kinoshita, Atsushi Kawaguchi, et al.
Neuro-Oncology|June 20, 2022
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomasAtsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, et al.
Acta Neuropathologica|August 31, 2017
Distinct molecular profile of diffuse cerebellar gliomasMasashi Nomura, Akitake Mukasa, Genta Nagae, et al.
Acta Neuropathologica|June 20, 2021
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaKenji Fujimoto, Hideyuki Arita, Kaishi Satomi, et al.
DEN Open|February 6, 2023
Local recurrence of submucosal invasive colorectal cancer after endoscopic submucosal dissection revealed by copy number variationYu Okazawa, Kiichi Sugimoto, Yuki Ii, et al.
Cancers|November 26, 2022
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker StudyMotoo Nagane, Koichi Ichimura, Ritsuko Onuki, et al.
Scientific Reports|September 21, 2023
Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumorsHirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Pageof 30